Pharmaceuticals, Corporate Crime and Public Health

Graham Dukes, John Braithwaite, J.P Moloney

    Research output: Book/ReportBook

    Abstract

    The pharmaceutical industry must exist to serve the community, but over the years it has engaged repeatedly in corporate crime and anti-social behaviour, with the public footing the bill. This readable study by experts in medicine, law, criminology and public health, with deep experience of the industry, documents problems ranging from false advertising and counterfeiting to corruption, fraud and overpricing. It is a fresh and revealing look at the unacceptable pressures brought to bear on doctors, politicians, patients and the media. Uniquely, the book presents realistic and worldwide solutions for the future, with positive policies encouraging honest dealing, as well as partial privatization of enforcement and a transformation of science policy to develop the medicines that society needs most. The authors examine in turn each of the main facets of the pharmaceutical industry's activities - research, manufacturing, information, distribution and pricing - as well as some questionable aspects of its relationship with society. Offering a considered analysis of pharmaceutical rights and wrongs as they have developed, particularly over the last half-century, this book is rich in new insights for managers in the pharmaceutical industry, regulatory agencies and health agencies.
    Original languageEnglish
    Place of PublicationCheltenham, UK and Northampton, MA, USA
    PublisherEdward Elgar Publishing Ltd.
    Number of pages424
    Edition1st
    ISBN (Print)9781783471096
    Publication statusPublished - 2014

    Fingerprint Dive into the research topics of 'Pharmaceuticals, Corporate Crime and Public Health'. Together they form a unique fingerprint.

    Cite this